Skip to main content

Advertisement

SpringerLink
Log in

Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review

  • Review
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Metastasis, whether regional or distant, remains the main cause of morbidity and recurrence in oral cancer. The accumulating evidence suggests that inflammatory mediators are strong drivers for cancer progression and spread. However, the precise role of these inflammatory mediators in mediating specific metastatic stage is poorly understood due to lack of integration/validation of experimental research data and the clinical trials, i.e., the data produced from research is not translated to clinical therapeutic targets. This, in turn, results in the lack of developing reliable biomarker that can be used for accurate diagnosis/prognosis of the tumour spread. We have performed a systematic review to assess the role of inflammatory mediators as potential markers for diagnosis/prognosis of oral squamous cell carcinoma (OSCC) metastasis. We carried out a systematic search the PubMed, Web of Science, Embase and Scopus databases under the guidelines for Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Australian National Health and Medical Research Council (NHMRC). Articles were divided into two groups; experimental (in-vivo) and clinical studies. The REporting recommendations for tumour MARKer prognostic studies Scale (REMARK) was used to assess the quality of the studies for the clinical search while Animal research: Reporting In-vivo experiments (ARRIVE) guidelines were used to assess the quality of the animal studies. Sixteen articles in the clinical group and four articles in the experimental group were included in the final review. We identified nine inflammatory mediators; CXCR4, CXCL12 (SDF-1), CCR7, IL-6, IL-18, CCL20 (MIP-3), CXCL1 (GRO-1), CCL3, CXCR2. This panel of inflammatory mediators can provide a framework for hypothesis testing of the potential value of these mediators in metastatic prognosis. We recommend carrying a large cohort study with data pooling for adequate assessment and testing of the inflammatory panel of mediators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer 127(12):2893–2917

    CAS  PubMed  Google Scholar 

  2. Howlader N (2011) Seer cancer statistics review, 1975–2008. http://seer.cancer.gov/csr/1975_2008/

  3. Yu X (2011) Epidemiology of cancer recurrence, second primary cancer, and comorbidity among cancer survivors health services for cancer survivors. Springer, New York, pp 277–297

    Google Scholar 

  4. Shah I, Sefvan O, Luqman U, Ibrahim W, Mehmood S, Alamgir W (2010) Clinical stage of oral cancer patients at the time of initial diagnosis. J Ayub Med Coll Abbottabad 22(3):61–63

    PubMed  Google Scholar 

  5. Silverman S (2003) Oral cancer, vol 1. PMPH-USA, Raleigh

    Google Scholar 

  6. Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45(4–5):309–316

    PubMed  Google Scholar 

  7. Amit M, Yen T, Liao C, Binenbaum Y, Chaturvedi P, Agarwal J, Kowalski L, Ebrahimi A, Clark J, Cernea C (2013) Clinical nodal stage is a significant predictor of outcome in patients with oral cavity squamous cell carcinoma and pathologically negative neck metastases: results of the international consortium for outcome research. Ann Surg Oncol 20(11):3575–3581

    CAS  PubMed  Google Scholar 

  8. Massano J, Regateiro FS, Januário G, Ferreira A (2006) Oral squamous cell carcinoma: Review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 102(1):67–76

    Google Scholar 

  9. Pulte D, Brenner H (2010) Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist 15(9):994–1001

    PubMed  PubMed Central  Google Scholar 

  10. El-Naaj IA, Leiser Y, Shveis M, Sabo E, Peled M (2011) Incidence of oral cancer occult metastasis and survival of t1-t2n0 oral cancer patients. J Oral Maxillofac Surg 69(10):2674–2679

    PubMed  Google Scholar 

  11. Furness S, Glenny AM, Worthington HV, Pavitt S, Oliver R, Clarkson JE, Macluskey M, Chan KK, Conway DI (2011) Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane Database Syst Rev 4:CD006386

    Google Scholar 

  12. Pignon J-P, Le Maitre A, Maillard E, Bourhis J (2009) Meta-analysis of chemotherapy in head and neck cancer (mach-nc): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92(1):4–14

    PubMed  Google Scholar 

  13. Chiang AC, Massagué J (2008) Molecular basis of metastasis. N Engl J Med 359(26):2814–2823

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Fidler IJ (2003) The pathogenesis of cancer metastasis: the seed and soil hypothesis revisited. Nat Rev Cancer 3(6):453–458

    CAS  PubMed  Google Scholar 

  15. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM (2010) Molecular interactions in cancer cell metastasis. Acta Histochem 112(1):3–25

    CAS  PubMed  Google Scholar 

  16. Zavadil J, Haley J, Kalluri R, Muthuswamy SK, Thompson E (2008) Epithelial-mesenchymal transition. AACR, Philadelphia

    Google Scholar 

  17. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3(6):401–410

    CAS  PubMed  Google Scholar 

  18. Wyckoff JB, Jones JG, Condeelis JS, Segall JE (2000) A critical step in metastasis: In vivo analysis of intravasation at the primary tumor. Can Res 60(9):2504–2511

    CAS  Google Scholar 

  19. Nguyen DX, Bos PD, Massagué J (2009) Metastasis: From dissemination to organ-specific colonization. Nat Rev Cancer 9(4):274–284

    CAS  PubMed  Google Scholar 

  20. Madsen CD, Sahai E (2010) Cancer dissemination—lessons from leukocytes. Dev Cell 19(1):13–26

    CAS  PubMed  Google Scholar 

  21. Wu Y, Zhou BP (2009) Inflammation: a driving force speeds cancer metastasis. Cell Cycle 8(20):3267–3273

    CAS  PubMed  Google Scholar 

  22. Desmoulière A (2008) Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. In: Paper presented at the 2nd Scar meeting

  23. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Perwez Hussain S, Harris CC (2007) Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121(11):2373–2380

    PubMed  Google Scholar 

  25. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674

    CAS  PubMed  Google Scholar 

  26. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23(36):9067–9072

    PubMed  Google Scholar 

  27. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010) Animal research: reporting in vivo experiments: the arrive guidelines. Br J Pharmacol 160(7):1577–1579

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Dupaul-Chicoine J, Saleh M (2013) Inflammatory mediators in tumorigenesis and metastasis. Experimental and clinical metastasis. Springer, New York, pp 101–127

    Google Scholar 

  29. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4(7):540–550

    CAS  PubMed  Google Scholar 

  30. Ishikawa T, Nakashiro K, Hara S, Klosek SK, Li C, Shintani S, Hamakawa H (2006) Cxcr4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma. Int J Oncol 28(1):61–66

    CAS  PubMed  Google Scholar 

  31. Oliveira-Neto HH, Silva ET, Leles CR, Mendonça EF, Alencar RdC, Silva TA, Batista AC (2008) Involvement of cxcl12 and cxcr4 in lymph node metastases and development of oral squamous cell carcinomas. Tumor Biol 29(4):262–271

    CAS  Google Scholar 

  32. Uchida D, Begum N-M, Almofti A, Nakashiro K-i, Kawamata H, Tateishi Y, Hamakawa H, Yoshida H, Sato M (2003) Possible role of stromal-cell-derived factor-1/cxcr4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res 290(2):289–302

    CAS  PubMed  Google Scholar 

  33. Meng X, Wuyi L, Yuhong X, Xinming C (2010) Expression of cxcr4 in oral squamous cell carcinoma: correlations with clinicopathology and pivotal role of proliferation. J Oral Pathol Med 39(1):63–68

    PubMed  Google Scholar 

  34. Albert S, Hourseau M, Halimi C, Serova M, Descatoire V, Barry B, Couvelard A, Riveiro ME, Tijeras-Raballand A, de Gramont A (2012) Prognostic value of the chemokine receptor cxcr4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue. Oral Oncol 48(12):1263–1271

    CAS  PubMed  Google Scholar 

  35. Lee J-I, Jin B-H, Kim M-A, Yoon H-J, Hong S-P, Hong S-D (2009) Prognostic significance of cxcr-4 expression in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 107(5):678–684

    Google Scholar 

  36. Uchida D, Onoue T, Tomizuka Y, Begum NM, Miwa Y, Yoshida H, Sato M (2007) Involvement of an autocrine stromal cell–derived factor-1/cxcr4 system on the distant metastasis of human oral squamous cell carcinoma. Mol Cancer Res 5(7):685–694

    CAS  PubMed  Google Scholar 

  37. Uchida D, Begum NM, Tomizuka Y, Bando T, Almofti A, Yoshida H, Sato M (2004) Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of cxcr4 in human oral squamous cell carcinoma. Lab Invest 84(12):1538–1546. https://doi.org/10.1038/labinvest.3700190

    Article  CAS  PubMed  Google Scholar 

  38. Förster R, Davalos-Misslitz AC, Rot A (2008) Ccr7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 8(5):362–371

    PubMed  Google Scholar 

  39. Mburu YK, Wang J, Wood MA, Walker WH, Ferris RL (2006) Ccr7 mediates inflammation-associated tumor progression. Immunol Res 36(1–3):61–72

    CAS  PubMed  Google Scholar 

  40. Xia X, Liu K, Zhang H, Shang Z (2015) Correlation between ccr7 expression and lymph node metastatic potential of human tongue carcinoma. Oral Dis 21(1):123–131

    CAS  PubMed  Google Scholar 

  41. Shang ZJ, Liu K, Shao Z (2009) Expression of chemokine receptor ccr7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma. Oral Oncol 45(6):480–485

    CAS  PubMed  Google Scholar 

  42. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813(5):878–888

    CAS  PubMed  Google Scholar 

  43. Schafer ZT, Brugge JS (2007) Il-6 involvement in epithelial cancers. J Clin Investig 117(12):3660–3663

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Shinriki S, Jono H, Ueda M, Ota K, Ota T, Sueyoshi T, Oike Y, Ibusuki M, Hiraki A, Nakayama H (2011) Interleukin-6 signalling regulates vascular endothelial growth factor-c synthesis and lymphangiogenesis in human oral squamous cell carcinoma. J Pathol 225(1):142–150

    CAS  PubMed  Google Scholar 

  45. Wang YF, Chang SY, Tai SK, Li WY, Wang LS (2002) Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head Neck 24(9):850–858

    PubMed  Google Scholar 

  46. Tsai HT, Hsin CH, Hsieh YH, Tang CH, Yang SF, Lin CW, Chen MK (2013) Impact of interleukin-18 polymorphisms − 607a/c and − 137 g/c on oral cancer occurrence and clinical progression. PLoS ONE 8(12):e83572. https://doi.org/10.1371/journal.pone.0083572

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Shintani S, Ishikawa T, Nonaka T, Li C, Nakashiro K-i, Wong DT, Hamakawa H (2004) Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer. Oncology 66(4):316–322

    CAS  PubMed  Google Scholar 

  48. Ghadjar P, Rubie C, Aebersold DM, Keilholz U (2009) The chemokine ccl20 and its receptor ccr6 in human malignancy with focus on colorectal cancer. Int J Cancer 125(4):741–745

    CAS  PubMed  Google Scholar 

  49. Wang B, Shi L, Sun X, Wang L, Wang X, Chen C (2016) Production of ccl 20 from lung cancer cells induces the cell migration and proliferation through pi 3k pathway. J Cell Mol Med 20(5):920–929

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Chang K-P, Kao H-K, Yen T-C, Chang Y-L, Liang Y, Liu S-C, Lee L-Y, Chang Y-L, Kang C-J, Chen I-H (2011) Overexpression of macrophage inflammatory protein-3α in oral cavity squamous cell carcinoma is associated with nodal metastasis. Oral Oncol 47(2):108–113

    CAS  PubMed  Google Scholar 

  51. Baba T, Mukaida N (2014) Role of macrophage inflammatory protein (mip)-1α/ccl3 in leukemogenesis. Mol Cell Oncol 1(1):e29899

    PubMed  PubMed Central  Google Scholar 

  52. De Oliveira-Neto HH, Watanabe S, Mendonça EF, Batista AC (2007) Dual role of ccl3/ccr1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense. Oncol Rep 18:1107–1113

    PubMed  Google Scholar 

  53. Allen F, Rauhe P, Askew D, Tong AA, Nthale J, Eid S, Myers JT, Tong C, Huang AY (2017) Ccl3 enhances antitumor immune priming in the lymph node via ifnγ with dependency on natural killer cells. Front Immunol 8:1390

    PubMed  PubMed Central  Google Scholar 

  54. Ha H, Debnath B, Neamati N (2017) Role of the cxcl8-cxcr1/2 axis in cancer and inflammatory diseases. Theranostics 7(6):1543

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Jaffer T, Ma D (2016) The emerging role of chemokine receptor cxcr2 in cancer progression. Transl Cancer Res 5(4):S616–S628

    CAS  Google Scholar 

  56. Steele CW, Karim SA, Leach JD, Bailey P, Upstill-Goddard R, Rishi L, Foth M, Bryson S, McDaid K, Wilson Z (2016) Cxcr2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma. Cancer Cell 29(6):832–845

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Qian Y, Wang Y, Li DS, Zhu YX, Lu ZW, Ji QH, Yang G (2014) The chemokine receptor-cxcr2 plays a critical role in the invasion and metastases of oral squamous cell carcinoma in vitro and in vivo. J Oral Pathol Med 43(9):658–666

    CAS  PubMed  Google Scholar 

  58. Shrihari T (2017) Dual role of inflammatory mediators in cancer. Ecancermedicalscience 11:721

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Guan X (2015) Cancer metastases: challenges and opportunities. Acta Pharm Sin B 5(5):402–418

    PubMed  PubMed Central  Google Scholar 

  60. Roca H, McCauley LK (2015) Inflammation and skeletal metastasis. BoneKEy Rep 4:706

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Liu K, Lu X, Zhu YS, Le N, Kim H, Poh CF (2018) Plasma-derived inflammatory proteins predict oral squamous cell carcinoma. Front Oncol 8:585. https://doi.org/10.3389/fonc.2018.00585

    Article  PubMed  PubMed Central  Google Scholar 

  62. Goertzen C, Mahdi H, Laliberte C, Meirson T, Eymael D, Gil-Henn H, Magalhaes M (2018) Oral inflammation promotes oral squamous cell carcinoma invasion. Oncotarget 9(49):29047–29063. https://doi.org/10.18632/oncotarget.25540

    Article  PubMed  PubMed Central  Google Scholar 

  63. Schaller TH, Batich KA, Suryadevara CM, Desai R, Sampson JH (2017) Chemokines as adjuvants for immunotherapy: implications for immune activation with ccl3. Expert Review Clin Immunol 13(11):1049–1060

    CAS  Google Scholar 

  64. Yan J, Wang Z-Y, Yang H-Z, Liu H-Z, Mi S, Lv X-X, Fu X-M, Yan H-M, Zhang X-W, Zhan Q-M (2011) Timing is critical for an effective anti-metastatic immunotherapy: the decisive role of ifnγ/stat1-mediated activation of autophagy. PLoS ONE 6(9):e24705

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Medicine and Dentistry, James Cook University, Cairns, QLD, 4878, Australia

    Moustafa Elhousiny, Kate Miller, Anura Ariyawadana & Alan Nimmo

  2. Griffith Health Institute, Gold Coast Campus, Griffith University, Gold Coast, Australia

    Anura Ariyawadana

  3. College of Public Health, Medical and Veterinary Sciences, James Cook University, Cairns, Australia

    Kate Miller

Authors
  1. Moustafa Elhousiny
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kate Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anura Ariyawadana
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alan Nimmo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Moustafa Elhousiny.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elhousiny, M., Miller, K., Ariyawadana, A. et al. Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review. Clin Exp Metastasis 36, 481–492 (2019). https://doi.org/10.1007/s10585-019-09994-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-019-09994-x

Keywords

Search

Navigation